Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers. [PDF]
Kim D +28 more
europepmc +1 more source
Regulation of neuronal CDC2 like kinase by wee1 like kinase
M. Matsushita +8 more
openaire +1 more source
Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer. [PDF]
Lee YY +13 more
europepmc +1 more source
Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition. [PDF]
Diab A +5 more
europepmc +1 more source
WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1- and S-phase cells. [PDF]
Moiseeva TN +4 more
europepmc +1 more source
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition. [PDF]
Chen X +17 more
europepmc +1 more source
Characterisation of WEE1 regulation at mitosis
Wee1 is a tyrosine kinase that plays a major role in regulating mitotic entry. Throughout G2 phase, it phosphorylates and inhibits Cdk1, the master mitotic regulator, thereby preventing mitotic entry.
Johnson, V
core
On the road to destruction: coupling cyclin B degradation to proteolysis independent MPF inactivation [PDF]
D'Angiolella, Vincenzo
core +1 more source
Combined Inhibition of Wee1 and Checkpoint Kinases Synergistically Provokes S-Phase Progression and Mitotic Entry, and Promotes Cell Death Under Heat Stress. [PDF]
Muratani T +8 more
europepmc +1 more source
WEE1 Inhibition as a Novel Therapeutic Strategy in Cutaneous T-Cell Lymphoma. [PDF]
Özistanbullu D +17 more
europepmc +1 more source

